Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8330213rdf:typepubmed:Citationlld:pubmed
pubmed-article:8330213lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:8330213lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8330213lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:8330213lifeskim:mentionsumls-concept:C0228398lld:lifeskim
pubmed-article:8330213lifeskim:mentionsumls-concept:C0025462lld:lifeskim
pubmed-article:8330213lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:8330213lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8330213pubmed:issue1-2lld:pubmed
pubmed-article:8330213pubmed:dateCreated1993-8-13lld:pubmed
pubmed-article:8330213pubmed:abstractTextThe midbrain periaqueductal gray (PAG) is involved in a variety of functions including pain modulation, vocalization, autonomic control, fear and anxiety. This area contains serotonin receptors, particularly 5-HT1A that are known to play a role in the above functions. The goals of this study were to characterize the effects of 8-OH-DPAT, a selective 5-HT1A agonist, on the firing characteristics and membrane properties of PAG neurons. Both in vivo and in vitro preparations were used. The effects of 8-OH-DPAT on baseline activity of 91 neurons were tested in the in vivo preparation. In 50/91 cells, 8-OH-DPAT produced a decrease in the firing rate that ranged between 21 and 98% (mean +/- S.E.M. decrease of 49 +/- 1.9%). This inhibitory effect was dose dependent and could be blocked by spiperone. In 10/91 cells, 8-OH-DPAT produced an increase in the firing rate that ranged between 13 and 290%, with mean increase of 83 +/- 7.4%. The baseline firing rate of the remaining 31 cells was not affected by 8-OH-DPAT. In the PAG slice preparation, the effects of 8-OH-DPAT on synaptic and membrane properties of 17 PAG neurons were tested using whole-cell voltage clamp-recording procedures. In 14 cells, application of 8-OH-DPAT produced hyperpolarization that ranged between 6 and 21 mV, with mean of 8.4 +/- 2.0 mV. This hyperpolarization was associated with a decrease in membrane impedance that ranged between 8 and 45%, with mean decrease of 21.6 +/- 4.5%. The remaining three neurons did not respond to 8-OH-DPAT.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8330213pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8330213pubmed:languageenglld:pubmed
pubmed-article:8330213pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8330213pubmed:citationSubsetIMlld:pubmed
pubmed-article:8330213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8330213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8330213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8330213pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8330213pubmed:statusMEDLINElld:pubmed
pubmed-article:8330213pubmed:monthMaylld:pubmed
pubmed-article:8330213pubmed:issn0006-8993lld:pubmed
pubmed-article:8330213pubmed:authorpubmed-author:PunR YRYlld:pubmed
pubmed-article:8330213pubmed:authorpubmed-author:LiuHHlld:pubmed
pubmed-article:8330213pubmed:authorpubmed-author:ShipleyM TMTlld:pubmed
pubmed-article:8330213pubmed:authorpubmed-author:BehbehaniM...lld:pubmed
pubmed-article:8330213pubmed:authorpubmed-author:JiangMMlld:pubmed
pubmed-article:8330213pubmed:issnTypePrintlld:pubmed
pubmed-article:8330213pubmed:day28lld:pubmed
pubmed-article:8330213pubmed:volume612lld:pubmed
pubmed-article:8330213pubmed:ownerNLMlld:pubmed
pubmed-article:8330213pubmed:authorsCompleteYlld:pubmed
pubmed-article:8330213pubmed:pagination56-60lld:pubmed
pubmed-article:8330213pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:meshHeadingpubmed-meshheading:8330213-...lld:pubmed
pubmed-article:8330213pubmed:year1993lld:pubmed
pubmed-article:8330213pubmed:articleTitleActivation of serotonin1A receptors inhibits midbrain periaqueductal gray neurons of the rat.lld:pubmed
pubmed-article:8330213pubmed:affiliationDepartment of Physiology, College of Medicine, University of Cincinnati, OH 45267-0576.lld:pubmed
pubmed-article:8330213pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8330213pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8330213pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8330213lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8330213lld:pubmed